Skip to content
10-K

Annual Report

CROSS COUNTRY HEALTHCARE INC CCRN

0001628280-26-015791

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 32.32M sh
Shares Diluted FY 2025 · Dec 31, 2025 32.41M sh
Shares Diluted FY 2025 · Dec 31, 2024 33.38M sh
Shares Diluted FY 2025 · Dec 31, 2023 35.48M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $6.83M
Stock Repurchased FY 2025 · Dec 31, 2024 $37.31M
Stock Repurchased FY 2025 · Dec 31, 2023 $57.65M
Capex FY 2025 · Dec 31, 2025 $8.16M
Capex FY 2025 · Dec 31, 2024 $8.71M
Capex FY 2025 · Dec 31, 2023 $13.97M
Operating Cash Flow FY 2025 · Dec 31, 2025 $48.25M
Operating Cash Flow FY 2025 · Dec 31, 2024 $120.12M
Operating Cash Flow FY 2025 · Dec 31, 2023 $248.5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $108.74M
Cash And Equivalents FY 2025 · Dec 31, 2024 $81.63M
Stockholders Equity FY 2025 · Dec 31, 2025 $322.82M
Stockholders Equity FY 2025 · Dec 31, 2024 $418.96M
Stockholders Equity restated FY 2025 · Dec 31, 2023 $467.65M
Stockholders Equity restated FY 2025 · Dec 31, 2022 $451.48M
Current Liabilities FY 2025 · Dec 31, 2025 $77.76M
Current Liabilities FY 2025 · Dec 31, 2024 $120.4M
Total Liabilities FY 2025 · Dec 31, 2025 $126.13M
Total Liabilities FY 2025 · Dec 31, 2024 $170.29M
Current Assets FY 2025 · Dec 31, 2025 $293.59M
Current Assets FY 2025 · Dec 31, 2024 $335M
Total Assets FY 2025 · Dec 31, 2025 $448.95M
Total Assets FY 2025 · Dec 31, 2024 $589.25M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.56
Eps Diluted FY 2025 · Dec 31, 2025 −$2.93
Eps Diluted FY 2025 · Sep 30, 2025 −$0.15
Eps Diluted FY 2025 · Jun 30, 2025 −$0.20
Eps Diluted FY 2025 · Mar 31, 2025 −$0.02
Eps Diluted FY 2025 · Dec 31, 2024 −$0.12
Eps Diluted FY 2025 · Dec 31, 2024 −$0.44
Eps Diluted FY 2025 · Sep 30, 2024 $0.08
Eps Diluted FY 2025 · Jun 30, 2024 −$0.47
Eps Diluted FY 2025 · Mar 31, 2024 $0.08
Eps Diluted FY 2025 · Dec 31, 2023 $2.05
Eps Basic FY 2025 · Dec 31, 2025 −$2.56
Eps Basic FY 2025 · Dec 31, 2025 −$2.93
Eps Basic FY 2025 · Sep 30, 2025 −$0.15
Eps Basic FY 2025 · Jun 30, 2025 −$0.20
Eps Basic FY 2025 · Mar 31, 2025 −$0.02
Eps Basic FY 2025 · Dec 31, 2024 −$0.12
Eps Basic FY 2025 · Dec 31, 2024 −$0.44
Eps Basic FY 2025 · Sep 30, 2024 $0.08
Eps Basic FY 2025 · Jun 30, 2024 −$0.47
Eps Basic FY 2025 · Mar 31, 2024 $0.08
Eps Basic FY 2025 · Dec 31, 2023 $2.07
Sga Expense FY 2025 · Dec 31, 2025 $200.68M
Sga Expense FY 2025 · Dec 31, 2024 $233.38M
Sga Expense restated FY 2025 · Dec 31, 2023 $300.33M
Net Income FY 2025 · Dec 31, 2025 −$82.93M
Net Income FY 2025 · Dec 31, 2025 −$94.85M
Net Income FY 2025 · Sep 30, 2025 −$4.77M
Net Income FY 2025 · Jun 30, 2025 −$6.66M
Net Income FY 2025 · Mar 31, 2025 −$490K
Net Income FY 2025 · Dec 31, 2024 −$3.75M
Net Income FY 2025 · Sep 30, 2024 $2.56M
Net Income FY 2025 · Jun 30, 2024 −$16.05M
Net Income FY 2025 · Mar 31, 2024 $2.69M
Operating Income FY 2025 · Dec 31, 2025 −$84.41M
Operating Income FY 2025 · Dec 31, 2024 −$16.87M
Operating Income FY 2025 · Dec 31, 2023 $112.71M
Gross Profit FY 2025 · Dec 31, 2025 $47.98M
Gross Profit FY 2025 · Sep 30, 2025 $50.93M
Gross Profit FY 2025 · Jun 30, 2025 $56M
Gross Profit FY 2025 · Mar 31, 2025 $58.66M
Gross Profit FY 2025 · Dec 31, 2024 $61.99M
Gross Profit FY 2025 · Sep 30, 2024 $64.16M
Gross Profit FY 2025 · Jun 30, 2024 $70.81M
Gross Profit FY 2025 · Mar 31, 2024 $77.3M
Revenue FY 2025 · Dec 31, 2025 $236.76M
Revenue FY 2025 · Dec 31, 2025 $1.05B
Revenue FY 2025 · Sep 30, 2025 $250.05M
Revenue FY 2025 · Jun 30, 2025 $274.07M
Revenue FY 2025 · Mar 31, 2025 $293.41M
Revenue FY 2025 · Dec 31, 2024 $309.94M
Revenue FY 2025 · Dec 31, 2024 $1.34B
Revenue FY 2025 · Sep 30, 2024 $315.12M
Revenue FY 2025 · Jun 30, 2024 $339.77M
Revenue FY 2025 · Mar 31, 2024 $379.17M
Revenue FY 2025 · Dec 31, 2023 $2.02B